• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cancer is not a single disease: is it safe to extrapolate evidence from trials of direct oral anticoagulants in cancer-associated venous thromboembolism to patients with haematological malignancies?

作者信息

Buka Richard J, Chandra Deepak, Sutton David J

机构信息

Clinical Haematology, University Hospitals North Midlands, Stoke-on-Trent, UK.

Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.

出版信息

Br J Haematol. 2021 Apr;193(1):194-197. doi: 10.1111/bjh.17123. Epub 2021 Feb 22.

DOI:10.1111/bjh.17123
PMID:33618429
Abstract
摘要

相似文献

1
Cancer is not a single disease: is it safe to extrapolate evidence from trials of direct oral anticoagulants in cancer-associated venous thromboembolism to patients with haematological malignancies?癌症并非单一疾病：将直接口服抗凝剂用于癌症相关静脉血栓栓塞症试验的证据外推至血液系统恶性肿瘤患者是否安全？
Br J Haematol. 2021 Apr;193(1):194-197. doi: 10.1111/bjh.17123. Epub 2021 Feb 22.
2
Direct oral anticoagulants and cancer-associated VTE: good for all, or just some?直接口服抗凝剂与癌症相关性静脉血栓栓塞症：适用于所有患者，还是仅适用于部分患者？
Blood. 2020 Aug 6;136(6):669-673. doi: 10.1182/blood.2019004177.
3
Treatment of Venous Thromboembolism in Cancer. Historical Perspective and Evolving Role of the Direct Oral Anticoagulants.癌症患者静脉血栓栓塞的治疗。直接口服抗凝剂的历史回顾与作用演变
Cancer Treat Res. 2019;179:103-115. doi: 10.1007/978-3-030-20315-3_7.
4
Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism.直接口服抗凝剂与传统抗凝剂在静脉血栓栓塞症中的安全性。
J Thromb Thrombolysis. 2019 Oct;48(3):439-453. doi: 10.1007/s11239-019-01878-x.
5
Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer.利伐沙班与低分子肝素治疗胃肠道和胰腺胆道恶性肿瘤相关静脉血栓栓塞症的比较。
J Korean Med Sci. 2019 Jun 2;34(21):e160. doi: 10.3346/jkms.2019.34.e160.
6
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis.直接口服抗凝剂治疗癌症相关静脉血栓栓塞症：系统评价和荟萃分析。
Blood. 2020 Sep 17;136(12):1433-1441. doi: 10.1182/blood.2020005819.
7
[CONKO-011: Evaluation of patient satisfaction with the treatment of acute venous thromboembolism with rivaroxaban or low molecular weight heparin in cancer patients. A randomized phase III study].[CONKO-011：评估利伐沙班或低分子肝素治疗癌症患者急性静脉血栓栓塞的患者满意度。一项随机III期研究]
Dtsch Med Wochenschr. 2015 Jun;140 Suppl 1:S22-3. doi: 10.1055/s-0041-101770. Epub 2015 Jun 11.
8
Low molecular weight heparin versus rivaroxaban in the treatment of venous thromboembolism in gastrointestinal malignancies.低分子量肝素与利伐沙班治疗胃肠道恶性肿瘤患者静脉血栓栓塞症的疗效比较
Blood Coagul Fibrinolysis. 2018 Mar;29(2):227-230. doi: 10.1097/MBC.0000000000000704.
9
Meta-Analysis Comparing Direct Oral Anticoagulants to Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Patients With Cancer.比较直接口服抗凝剂与低分子肝素治疗癌症患者静脉血栓栓塞的Meta分析
Am J Cardiol. 2020 Oct 15;133:175-178. doi: 10.1016/j.amjcard.2020.07.027. Epub 2020 Jul 25.
10
Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis.直接口服抗凝剂治疗伴癌急性静脉血栓栓塞症：系统评价和荟萃分析。
Thromb Haemost. 2020 Jul;120(7):1128-1136. doi: 10.1055/s-0040-1712098. Epub 2020 May 4.

引用本文的文献

1
Causal relationship between 14 site-specific cancers and venous thromboembolism.14种特定部位癌症与静脉血栓栓塞之间的因果关系。
Cancer Innov. 2022 Dec 7;1(4):316-327. doi: 10.1002/cai2.36. eCollection 2022 Dec.
2
Direct oral anticoagulants in patients with venous thromboembolism and hematological malignancies.直接口服抗凝剂用于静脉血栓栓塞症和血液系统恶性肿瘤患者
J Thromb Thrombolysis. 2023 May;55(4):729-736. doi: 10.1007/s11239-023-02791-0. Epub 2023 Mar 21.